Sana Health

Executive Summary

Sana Health is a San Diego-based digital health and neuroscience company developing a non-invasive wearable device that delivers audiovisual neuromodulation to manage chronic pain and improve mental well-being. Founded in 2016 by a patient with severe nerve damage, the company translates personal anecdotal success into rigorous clinical evidence. Its technology uses precisely-timed audio and visual stimuli to modulate brain activity, offering a drug-free alternative for conditions like neuropathic pain and PTSD. Sana Health has attracted funding from the U.S. Department of Defense and is positioned to address a large unmet need in pain management and mental health. The company has submitted pivotal clinical data to the FDA for its neuropathic pain indication, representing a near-term regulatory catalyst. Concurrently, it is investigating the device for PTSD with DoD support. If FDA clearance is obtained, Sana Health could become the first approved digital therapeutic for chronic pain using neuromodulation. However, the company remains private and early-stage, with regulatory and commercial risks. Its success hinges on positive FDA feedback, expansion into additional indications, and securing further funding to scale manufacturing and commercialization.

Upcoming Catalysts (preview)

• Q3 2026FDA decision on neuropathic pain indication70% success
• Q1 2027Topline results from PTSD clinical trial funded by DoD60% success
• Q4 2026Series A or B funding round50% success